PRX-OTC

N/A

Report date: 2023/04/23 17:24:37

Base Information

Drug NamePRX-OTC

Drug Alias NameModified messenger ribonucleic acid encoding human ornithine transcarbamylase enzyme encapsulated into lipid nanoparticlesPRX-OTCPRX-OD1

ClassificationBiologics

Mechanisms of ActionOrnithine carbamoyltransferase stimulants

TargetsOrnithine carbamoyltransferase

Therapy Area/IndicationsEndocrine System DiseasesMetabolic Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending

Highest Status in ChinaN/A

Originator CompaniesPhaseRx Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsEndocrine System DiseasesMetabolic Diseases

Other Information

ATC CodeN/A